Call for Participants:

 

vf

Virta-Flaneurazine Clinical Trial Information:

The purpose of this research study is to study the wanderment effects of Virta-Flaneurazine on Second Life Avatars and their first life owners. 

What is Virta-Flaneurazine?

Study drug information is available to you at:
https://virtaflaneurazine.wordpress.com/

How do I obtain and take Virta-Flaneurazine?

Study procedures are available to you at:
https://virtaflaneurazine.wordpress.com/trial/

To qualify, you must:

• Be at least 18 years old
• Have access to a computer* with a broadband internet connection or come to a real world exhibition clinic when they are open**.
• Have access to a recent version of Second Life http://secondlife.com/support/downloads.php
• Have an avatar and be able to walk forward and turn in Second Life

You will not qualify if you:

• Have no time to explore the internet.
• Have not participated in a drug experience in your lifetime.

Contact:

Dr.* WD Pappenheimer
Dr.* JC Freeman
virtaflaneurazine@gmail.com

PLEASE NOTE: the initial trials will require Macintosh OS. PC versions will be developed soon.

Current or scheduled real world clinics:

Exhibition Dates: September 6 – October 4, 2008
Fringe Exhibitions
504 Chung King Court
Los Angeles, CA 90012
(213) 613-0160

4 Responses to “Call for Participants:”

  1. First Prescriptions « Virta-Flaneurazine Says:

    […] for the the launch of clinical trials at Fringe Exhibitions in LA. Though participation can also be initiated online, a real world clinic will be set up where patients can meet with the Dr.s* and receive a more […]

  2. VF Launch at Fringe Exhibitions, LA « Says:

    […] for the the launch of clinical trials at Fringe Exhibitions in LA. Though participation can also be initiated online, a real world clinic will be set up where patients can meet with the Dr.s* and receive a more […]

  3. sandrar Says:

    Hi! I was surfing and found your blog post… nice! I love your blog. 🙂 Cheers! Sandra. R.

  4. Funk Says:

    cool picsxxx

Leave a comment